These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31742432)

  • 21. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large-scale whole-genome sequencing analysis reveals highly specific genome editing by both Cas9 and Cpf1 (Cas12a) nucleases in rice.
    Tang X; Liu G; Zhou J; Ren Q; You Q; Tian L; Xin X; Zhong Z; Liu B; Zheng X; Zhang D; Malzahn A; Gong Z; Qi Y; Zhang T; Zhang Y
    Genome Biol; 2018 Jul; 19(1):84. PubMed ID: 29973285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Agrobacterium-delivered CRISPR/Cas9 system for high-frequency targeted mutagenesis in maize.
    Char SN; Neelakandan AK; Nahampun H; Frame B; Main M; Spalding MH; Becraft PW; Meyers BC; Walbot V; Wang K; Yang B
    Plant Biotechnol J; 2017 Feb; 15(2):257-268. PubMed ID: 27510362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm.
    Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y
    J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling.
    Jo N; Sogabe Y; Yamada Y; Ukai T; Kagawa H; Mitsunaga K; Woltjen K; Yamada Y
    Cancer Sci; 2019 Mar; 110(3):926-938. PubMed ID: 30588718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering guide RNA to reduce the off-target effects of CRISPR.
    Wu J; Yin H
    J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric DNA-RNA Guide RNA Designs.
    Lu S; Zhang Y; Yin H
    Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-P 2.0: An Improved CRISPR-Cas9 Tool for Genome Editing in Plants.
    Liu H; Ding Y; Zhou Y; Jin W; Xie K; Chen LL
    Mol Plant; 2017 Mar; 10(3):530-532. PubMed ID: 28089950
    [No Abstract]   [Full Text] [Related]  

  • 30. Genome Editing in Penicillium chrysogenum Using Cas9 Ribonucleoprotein Particles.
    Pohl C; Mózsik L; Driessen AJM; Bovenberg RAL; Nygård YI
    Methods Mol Biol; 2018; 1772():213-232. PubMed ID: 29754231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On- and Off-Target Damage: Techniques for Detecting, Predicting, and Mitigating the On- and off-target Effects of Cas9 Editing.
    Newman A; Starrs L; Burgio G
    Bioessays; 2020 Sep; 42(9):e2000047. PubMed ID: 32643177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
    Zhang B; Zhou J; Li M; Wei Y; Wang J; Wang Y; Shi P; Li X; Huang Z; Tang H; Song Z
    Anal Bioanal Chem; 2021 Apr; 413(9):2447-2456. PubMed ID: 33661348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells.
    Jayavaradhan R; Pillis DM; Malik P
    J Mol Biol; 2019 Jan; 431(1):102-110. PubMed ID: 29751014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient and Heritable Targeted Mutagenesis in Mosses Using the CRISPR/Cas9 System.
    Nomura T; Sakurai T; Osakabe Y; Osakabe K; Sakakibara H
    Plant Cell Physiol; 2016 Dec; 57(12):2600-2610. PubMed ID: 27986915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites.
    Dabrowska M; Czubak K; Juzwa W; Krzyzosiak WJ; Olejniczak M; Kozlowski P
    Nucleic Acids Res; 2018 Sep; 46(17):e101. PubMed ID: 29878242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimizing off-target effects in CRISPR-Cas9 genome editing.
    Chen SJ
    Cell Biol Toxicol; 2019 Oct; 35(5):399-401. PubMed ID: 31317359
    [No Abstract]   [Full Text] [Related]  

  • 38. Battling CRISPR-Cas9 off-target genome editing.
    Li D; Zhou H; Zeng X
    Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
    [No Abstract]   [Full Text] [Related]  

  • 39. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
    He Z; Kee K
    Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.